A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Phase

Condition

Bladder Disorders

Prostate Disorders

Treatment

N/A

Clinical Study ID

NCT00224120

SI04010

Ages > 50
Male

Study Summary

A new drug for benign prostatic hyperplasia is compared to placebo for to determine if it is safe and effective. The study lasts approximately 20 weeks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Males in good general health and at least 50 years of age, with symptoms of moderateto severe BPH.

Exclusion

Exclusion Criteria:

Medical conditions that would confound the efficacy evaluation.
Medical conditions in which it would be unsafe to use an alpha-blocker.
The use of concomitant drugs that would confound the efficacy evaluation.
The use of concomitant drugs that would be unsafe with this alpha-blocker.

Study Design

May 01, 2005

May 31, 2006

Study Description

This will be a multi-center, double-blind, placebo controlled, parallel, 12 week treatment trial in men with signs and symptoms of benign prostatic hyperplasia. the following procedures are utilized: physical exams, electrocardiograms, clinical laboratory tests, vital signs, the Internation Prostate Symptom Score, maximum urine flow rate, pharmacokinetics, adverse events, concomitant medications, quality of life, and compliance.

Connect with a study center

Birmingham, Alabama
United States
Site Not Available
Carmichael, California
United States
Site Not Available
Fresno, California
United States
Site Not Available
Laguna Woods, California
United States
Site Not Available
San Bernardino, California
United States
Site Not Available
Tarzana, California
United States
Site Not Available
Torrance, California
United States
Site Not Available
New Port Richey, Florida
United States
Site Not Available
Ocala, Florida
United States
Site Not Available
Orlando, Florida
United States
Site Not Available
Plantation, Florida
United States
Site Not Available
Tampa, Florida
United States
Site Not Available
West Palm Beach, Florida
United States
Site Not Available
Chicago, Illinois
United States
Site Not Available
Melrose Park, Illinois
United States
Site Not Available
Evansville, Indiana
United States
Site Not Available
Fort Wayne, Indiana
United States
Site Not Available
Overland Park, Kansas
United States
Site Not Available
Greenbelt, Maryland
United States
Site Not Available
Boston, Massachusetts
United States
Site Not Available
Jackson, Mississippi
United States
Site Not Available
Kansas City, Missouri
United States
Site Not Available
Lawrenceville, New Jersey
United States
Site Not Available
Voorhees, New Jersey
United States
Site Not Available
Albuquerque, New Mexico
United States
Site Not Available
Albany, New York
United States
Site Not Available
Garden City, New York
United States
Site Not Available
Kingston, New York
United States
Site Not Available
Poughkeepsie, New York
United States
Site Not Available
Concord, North Carolina
United States
Site Not Available
Cincinnati, Ohio
United States
Site Not Available
Portland, Oregon
United States
Site Not Available
Providence, Rhode Island
United States
Site Not Available
Mt. Pleasant, South Carolina
United States
Site Not Available
Myrtle Beach, South Carolina
United States
Site Not Available
Austin, Texas
United States
Site Not Available
Dallas, Texas
United States
Site Not Available
San Antonio, Texas
United States
Site Not Available
Norfolk, Virginia
United States
Site Not Available
Seattle, Washington
United States
Site Not Available
Tacoma, Washington
United States
Site Not Available
Madison, Wisconsin
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.